SEC Form 4 · accession 0001140361-26-029341
ANGIODYNAMICS INC · ANGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jan Stern Reed
Director
Period of report
Jul 15, 2026
Accepted (ET)
Jul 22, 2026 · 8:06 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001275187
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 15, 2026 | A | 11,887 | $0.00 | A | 116,921 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The acquisition of 11,887 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 11,887 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant.